Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Condition Approved
For
Bapineuzumab AAB-001 Discontinued Janssen, Pfizer Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
Gammagard™ Intravenous Immunoglobulin,
IVIg
Discontinued Baxter Healthcare Amyloid-Related, Inflammation Immunotherapy (passive) Alzheimer's Disease Immunodeficiency conditions
Ponezumab PF-04360365 Discontinued, 2 Pfizer Amyloid-Related Immunotherapy (passive) Alzheimer's Disease, Cerebral Amyloid Angiopathy None